Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease
Marine Drugs · 2023
DOI: 10.3390/md21030141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Tanatcha Sanguanphun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand. Hauptthemen laut MEDLINE: Parkinson Disease, Holothuria, Neurodegenerative Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Mahidol University, Science Achievement Scholarship of Thailand.
Abstract (Originalsprache)
Parkinson’s disease (PD) is the second most common neurodegenerative disease which is still incurable. Sea cucumber-derived compounds have been reported to be promising candidate drugs for treating age-related neurological disorders. The present study evaluated the beneficial effects of the Holothuria leucospilota (H. leucospilota)-derived compound 3 isolated from ethyl acetate fraction (HLEA-P3) using Caenorhabditis elegans PD models. HLEA-P3 (1 to 50 µg/mL) restored the viability of dopaminergic neurons. Surprisingly, 5 and 25 µg/mL HLEA-P3 improved dopamine-dependent behaviors, reduced oxidative stress and prolonged lifespan of PD worms induced by neurotoxin 6-hydroxydopamine (6-OHDA). Additionally, HLEA-P3 (5 to 50 µg/mL) decreased α-synuclein aggregation. Particularly, 5 and 25 µg/mL HLEA-P3 improved locomotion, reduced lipid accumulation and extended lifespan of transgenic C. elegans strain NL5901. Gene expression analysis revealed that treatment with 5 and 25 µg/mL HLEA-P3 could upregulate the genes encoding antioxidant enzymes (gst-4, gst-10 and gcs-1) and autophagic mediators (bec-1 and atg-7) and downregulate the fatty acid desaturase gene (fat-5). These findings explained the molecular mechanism of HLEA-P3-mediated protection against PD-like pathologies. The chemical characterization elucidated that HLEA-P3 is palmitic acid. Taken together, these findings revealed the anti-Parkinson effects of H. leucospilota-derived palmitic acid in 6-OHDA induced- and α-synuclein-based models of PD which might be useful in nutritional therapy for treating PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand.
- Molecular Medicine Program, Multidisciplinary Unit, Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand.
- Department of Chemistry, Faculty of Science, King Mongkut's University of Technology Thonburi, Bang Mod, Bangkok 10140, Thailand.
- Chemistry Program, Department of Science, Faculty of Science and Technology, Bansomdejchaopraya Rajabhat University, Bangkok 10600, Thailand.
- Center for Neuroscience, Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand.
ORCID-Profile: Sukrit Promtang, Nakorn Niamnont, Krai Meemon
Förderung
- NIH HHS
- Mahidol University
- Science Achievement Scholarship of Thailand
- NIH Office of Research Infrastructure
Zitieren
APA
Sanguanphun, T., Promtang, S., Sornkaew, N., Niamnont, N., Sobhon, P., & Meemon, K. (2023). Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease. Marine Drugs. https://doi.org/10.3390/md21030141
Vancouver
Sanguanphun T, Promtang S, Sornkaew N, Niamnont N, Sobhon P, Meemon K. Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease. Marine Drugs. 2023. doi:10.3390/md21030141
BibTeX
@article{Sanguanphun2023,
author = {Sanguanphun, Tanatcha and Promtang, Sukrit and Sornkaew, Nilubon and Niamnont, Nakorn and Sobhon, Prasert and Meemon, Krai},
title = {Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21030141}
}
EUVIMED